These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30325416)

  • 1. Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: a molecular dynamics study.
    Harbison AM; Brosnan LP; Fenlon K; Fadda E
    Glycobiology; 2019 Jan; 29(1):94-103. PubMed ID: 30325416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics.
    Harbison A; Fadda E
    Glycobiology; 2020 May; 30(6):407-414. PubMed ID: 31829411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Fc N-glycan sialylation on IgG structure.
    Zhang Z; Shah B; Richardson J
    MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y; Satoh T; Yagi H; Yanaka S; Yamaguchi T; Isoda Y; Iida S; Okamoto Y; Kato K
    Sci Rep; 2017 Oct; 7(1):13780. PubMed ID: 29062024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
    Wada R; Matsui M; Kawasaki N
    MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.
    Chen CL; Hsu JC; Lin CW; Wang CH; Tsai MH; Wu CY; Wong CH; Ma C
    ACS Chem Biol; 2017 May; 12(5):1335-1345. PubMed ID: 28318221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating IgG effector function by Fc glycan engineering.
    Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3485-3490. PubMed ID: 28289219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions.
    Mattu TS; Pleass RJ; Willis AC; Kilian M; Wormald MR; Lellouch AC; Rudd PM; Woof JM; Dwek RA
    J Biol Chem; 1998 Jan; 273(4):2260-72. PubMed ID: 9442070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
    MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.
    Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F
    MAbs; 2015; 7(5):863-70. PubMed ID: 26067753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
    Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
    J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel roles for the IgG Fc glycan.
    Anthony RM; Wermeling F; Ravetch JV
    Ann N Y Acad Sci; 2012 Apr; 1253():170-80. PubMed ID: 22288459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.
    Scallon BJ; Tam SH; McCarthy SG; Cai AN; Raju TS
    Mol Immunol; 2007 Mar; 44(7):1524-34. PubMed ID: 17045339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis.
    Fang J; Richardson J; Du Z; Zhang Z
    Biochemistry; 2016 Feb; 55(6):860-8. PubMed ID: 26812426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR assignments of the N-glycans of the Fc fragment of mouse immunoglobulin G2b glycoprotein.
    Yanaka S; Yamaguchi Y; Takizawa T; Miyanoiri Y; Yogo R; Shimada I; Kato K
    Biomol NMR Assign; 2021 Apr; 15(1):187-192. PubMed ID: 33423189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.
    Mizushima T; Yagi H; Takemoto E; Shibata-Koyama M; Isoda Y; Iida S; Masuda K; Satoh M; Kato K
    Genes Cells; 2011 Nov; 16(11):1071-80. PubMed ID: 22023369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological activities of anti-HER2 monoclonal antibodies with multibranched complex-type N-glycans.
    Takashima S; Kurogochi M; Tsukimura W; Mori M; Osumi K; Sugawara SI; Amano J; Mizuno M; Takada Y; Matsuda A
    Glycobiology; 2021 Nov; 31(10):1401-1414. PubMed ID: 34192331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.